Extraction and Purification. The dried fruits (5 kg) were exhaustively extracted with 60% EtOH, and the extract
was concentrated under reduced pressure to obtain a crude residue (166 g), which was chromatographed over a D macroporous
101
resin column (10 ꢆ 80 cm) and eluted successively with H O, 30% EtOH, and 70% EtOH. The 70% EtOH eluate was concentrated
2
to dryness (15 g saponin mixture) and chromatographed over a silica gel column (200–300 mesh) eluted with CHCl –MeOH–
3
H O 30:10:1ꢂ10:10:1 to give fractions 1–4. Fraction 2 was subjected to HPLC (column: 10 ꢆ 250 mm, RP-18, 10 ꢇm, flow
2
rate: 3.0 mL/min) with MeOH–H O (65:35) as mobile phase to afford 1 (45 mg), 3 (29 mg), and 4 (23 mg). Fraction 4 was
2
subjected to HPLC eluting with MeOH–H O (60:40) to afford 2 (38 mg), 5 (26 mg).
2
Acid Hydrolysis of Compound 1. The saponin (10 mg) was heated with 2M HCl–MeOH (10 mL) under reflux for
3 h. The reaction mixture was diluted with H O and extracted with CHCl . The water layer was neutralized with Na CO ,
2
3
2
3
concentrated, and subjected to TLC analysis with authentic samples of D-glucose and L-galactose, and developed with
CH Cl –MeOH–H O (15:6:1). Detection was carried out with aniline phthalate spray.
2
2
2
25
Compound 1, C H O , white amorphous powder, mp 212ꢈC (dec.),
+4.6ꢈ (c 1.25; pyridine); HR-FAB-MS
[ꢁ]D
45 72 22
–
–1
m/z: 931.46276 (calcd for C H O , 931.46169); ESI-MS: 931 [M – H] ; IR (KBr, ꢉ , cm ): 3420 (OH), 1702 (C=O),
1624 (C=C). H NMR and C NMR, as well as HMBC and HMQC; for spectral data, see Tables 1 and 2 and Fig. 1.
45 72 22
max
1
13
25
Compound 2, C H O , white amorphous powder, mp 202ꢈC (dec.),
+2.6ꢈ (c 1.25; pyridine), ESI-MS m/z:
+6.0ꢈ (c 0.3; pyridine), ESI-MS m/z:
–18.4ꢈ (c 0.50; pyridine), ESI-MS
[ꢁ]D
51 82 24
–
13
1077 [M – H] ; for C NMR, see Tables 1 and 2.
20
Compound 3, C H O , white amorphous powder, mp 205ꢈC (dec.),
[ꢁ]D
45 72 19
–
13
915 [M – H] ; for C NMR, see Tables 1 and 2.
[ꢁ]2D0
Compound 4, C H O white amorphous powder, mp 228ꢈC (dec.),
45 74 20,
–
13
m/z: 935 [M – H] ; for C NMR, see Tables 1 and 2.
20
Compound 5, C H O , white amorphous powder, mp 216ꢈC (dec.),
–69ꢈ (c 0.50; MeOH), ESI-MS m/z:
[ꢁ]D
62 104 31
13
1369 [M + Na]+; for C NMR, see Tables 1 and 2.
ACKNOWLEDGMENT
The authors are grateful to the Program for New Century Excellent Talents in University (NCET-08-0746) and
Cooperation Program of the Beijing Municipal Education Commission, and the National Natural Science Foundation of China
(No. 30873357).
REFERENCES
1.
2.
3.
4.
5.
6.
7.
8.
9.
P. G. Xiao, Modern Chinese Materia Medica, (I), Chemical Industry Press, Beijing, 2001, p. 481.
E. D. Perepelktsa and P. K. Kintya, Khim. Prir. Soedin, 11, 260 (1975).
S. B. Mahato, N. P. Sahu, and A. N. Ganguiy, J. Chem. Soc. Perkin Trans. 1, 9, 2405 (1981).
M. Tomova, D. Panova, and N. S. Wulfson, Planta Med., 25, 231 (1974).
H. C. Sharma and J. L. Narula, Chem. Era., 13, 15 (1977).
Y. Wang, K. Ohtani, R. Kasai, and K. Yamasaki, Phytochemistry, 45, 811 (1997).
L. F. Cai, F. Y. Jing, J. G. Zhang, F. K. Pei, Y. J. Xu, S. Y. Liu, and D. M. Xu, Acta Pharm. Sin., 34, 759 (1999).
Y. X. Xu, H. S. Chen, H. Q. Liang, Z. B. Gu, W. Y. Liu, W. N. Leung, and T. J. Li, Planta Med., 66, 545 (2000).
T. H. Xu, Y. J. Xu, S. X. Xie, H. F. Zhao, D. Han, Y. Lu, J. Z. Niu, and D. M. Xu, J. Asia Nat. Prod. Res., 10,
419 (2008).
10.
11.
T. Murakami, A. Kishi, H. Matsuda, and M. Yoshikawa, Chem. Pharm. Bull., 48, 994 (2000).
M. Yoshikawa, T. Murakami, H. Komatsu, N. Murakami, J. Yamahara, and H. Mtsuda, Chem. Pharm. Bull., 45,
81 (1997).
12.
13.
P. K. Agrawal, Phytochemistry, 31, 3307 (1992).
P. K. Agrawal, D. C. Jain, R. K. Gupta, and R. S. Thakur, Phytochemistry, 24, 2479 (1985).
245